Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anannya Patwari

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Hematology|May 5, 2020
Diagnostic Dilemma: An Unusual Case of Angioimmunoblastic T-Cell Lymphoma Manifesting as Bone Marrow Non-Caseating GranulomaVineel Bhatlapenumarthi, Anannya Patwari, Sheila Karina Pascual
Case Reports in Oncology|October 1, 2020
Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case ReportAnannya Patwari, Vineel Bhatlapenumarthi, Sheila K Pascual
Journal of Cancer Research and Clinical Oncology|March 28, 2021
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experienceVineel Bhatlapenumarthi, Anannya Patwari, Antoine J Harb
Cureus|November 14, 2019
An Unusual Case of Enteropathy-associated T-cell Lymphoma Type 2 with Pulmonary MetastasisVineel Bhatlapenumarthi, Anannya Patwari, Ahmad D Siddiqui
Cureus|May 28, 2019
Pancytopenia: A Rare and Unusual Initial Presentation of Breast CancerVishal Jindal, Anannya Patwari, Vineel Bhatlapenumarthi, et al.
JCO Oncology Advances|January 22, 2026
PD-L2 Landscape and Correlation with Outcome: An Immunomic AnalysisAnannya Patwari, Daisuke Nishizaki, Taylor Jensen, et al.
Blood|August 28, 2024
Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapyRajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, et al.
Blood Cancer Journal|March 5, 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world studyMeera Mohan, Jorge Monge, Nishi Shah, et al.
Hemasphere|December 31, 2025
Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab eraAbdul-Hamid Bazarbachi, Saurabh Zanwar, Ute Hegenbart, et al.
Bone Marrow Transplantation|February 16, 2024
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myelomaMeera Mohan, Aniko Szabo, Anannya Patwari, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Hematology|May 5, 2020
Diagnostic Dilemma: An Unusual Case of Angioimmunoblastic T-Cell Lymphoma Manifesting as Bone Marrow Non-Caseating GranulomaVineel Bhatlapenumarthi, Anannya Patwari, Sheila Karina Pascual
Case Reports in Oncology|October 1, 2020
Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case ReportAnannya Patwari, Vineel Bhatlapenumarthi, Sheila K Pascual
Journal of Cancer Research and Clinical Oncology|March 28, 2021
Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experienceVineel Bhatlapenumarthi, Anannya Patwari, Antoine J Harb
Cureus|November 14, 2019
An Unusual Case of Enteropathy-associated T-cell Lymphoma Type 2 with Pulmonary MetastasisVineel Bhatlapenumarthi, Anannya Patwari, Ahmad D Siddiqui
Cureus|May 28, 2019
Pancytopenia: A Rare and Unusual Initial Presentation of Breast CancerVishal Jindal, Anannya Patwari, Vineel Bhatlapenumarthi, et al.
JCO Oncology Advances|January 22, 2026
PD-L2 Landscape and Correlation with Outcome: An Immunomic AnalysisAnannya Patwari, Daisuke Nishizaki, Taylor Jensen, et al.
Blood|August 28, 2024
Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapyRajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, et al.
Blood Cancer Journal|March 5, 2024
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world studyMeera Mohan, Jorge Monge, Nishi Shah, et al.
Hemasphere|December 31, 2025
Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab eraAbdul-Hamid Bazarbachi, Saurabh Zanwar, Ute Hegenbart, et al.
Bone Marrow Transplantation|February 16, 2024
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myelomaMeera Mohan, Aniko Szabo, Anannya Patwari, et al.
Pageof 2